Wanbury

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE107F01022
  • NSEID: WANBURY
  • BSEID: 524212
INR
179.25
-3.3 (-1.81%)
BSENSE

Nov 20

BSE+NSE Vol: 1.68 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Valiant Laborato
Trident Lifeline
Kilitch Drugs
Anuh Pharma
Haleos Labs Limi
Shree Ganesh Rem
Zim Laboratories
Wanbury
Transchem
Influx Health.
Infinium Pharma
Why is Wanbury Ltd ?
1
High Debt Company with a Debt to Equity ratio (avg) at 2.90 times
  • Poor long term growth as Net Sales has grown by an annual rate of 6.98% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 2.90 times
2
Flat results in Sep 26
  • PAT(Q) At Rs 11.88 cr has Fallen at -20.1% (vs previous 4Q average)
3
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 05-Oct-26 and has generated -5.31% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
  • Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
5
Underperformed the market in the last 1 year
  • Even though the market (BSE500) has generated returns of 0.37% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -22.34% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Wanbury for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Wanbury
-22.34%
-0.39
57.95%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.98%
EBIT Growth (5y)
40.54%
EBIT to Interest (avg)
1.36
Debt to EBITDA (avg)
2.17
Net Debt to Equity (avg)
1.44
Sales to Capital Employed (avg)
2.95
Tax Ratio
6.09%
Dividend Payout Ratio
0
Pledged Shares
5.49%
Institutional Holding
0.74%
ROCE (avg)
30.89%
ROE (avg)
24.74%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
14
Industry P/E
40
Price to Book Value
3.99
EV to EBIT
11.20
EV to EBITDA
9.40
EV to Capital Employed
2.23
EV to Sales
1.31
PEG Ratio
2.70
Dividend Yield
NA
ROCE (Latest)
19.88%
ROE (Latest)
27.71%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
NET SALES(Q)

Highest at Rs 182.91 cr

OPERATING PROFIT TO INTEREST(Q)

Highest at 4.14 times

-6What is not working for the Company
PAT(Q)

At Rs 11.88 cr has Fallen at -20.1% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is working for Wanbury
Net Sales - Quarterly
Highest at Rs 182.91 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 4.14 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Here's what is not working for Wanbury
Profit After Tax (PAT) - Quarterly
At Rs 11.88 cr has Fallen at -20.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 14.87 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)